And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Donald Braun Biography and Net Worth

Director of Imunon

Dr. Braun joined Celsion in 2015 and brings over 30 years of research expertise in oncology, with a focus on immunotherapy and the effectiveness and impact of chemotherapy protocols on various cancers and tumor types. Prior to his retirement in 2016 Dr. Braun served as Vice President Translational Research and Chief Science Officer at the Cancer Treatment Centers of America. Prior to the CTCA, he was the Scientific Director of the Cancer Center and Professor of Medicine and Immunology at Rush Medical College in Chicago, and the Administrative Director of the Cancer Institute and a Professor of Surgery with tenure at the Medical College of Ohio. Dr. Braun has been appointed to and served on more than a dozen federal government and public advisory committees on oncology and immunology. He received his PhD in Immunology and Microbiology from the University of Illinois at the Medical Center in Chicago.

How do I contact Donald P. Braun?: The corporate mailing address for Dr. Braun and other Imunon executives is 997 LENOX DRIVE SUITE 100, LAWRENCEVILLE NJ, 08648. Imunon can also be reached via phone at (609) 896-9100 and via email at [email protected]. Learn More on Donald P. Braun's contact information.
Has Donald P. Braun been buying or selling shares of Imunon?: Donald P. Braun has not been actively trading shares of Imunon in the last ninety days. Learn More on Donald P. Braun's trading history.
Who are Imunon's active insiders?: Imunon's insider roster includes Donald Braun (Director), and Frederick Fritz (Director). Learn More on Imunon's active insiders.

Donald P. Braun Insider Trading History at Imunon

Donald P. Braun Buying and Selling Activity at Imunon

Imunon Company Overview

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Today's Range

Now: N/A

50 Day Range

MA: $2.22

$1.95

$2.63

2 Week Range

Now: N/A

Volume

711 shs

Average Volume

150,471 shs

Market Capitalization

$13.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.27

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here